Merck KGaA
The Top Pharma List rankings are compiled from GlobalData’s pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. Listed below are the charts and positions for Merck KGaA in this year’s pharmaceutical sales data alongside recent articles on PMLiVE featuring Merck KGaA.
Recent articles on PMLiVE featuring Merck KGaA
Cladribine capsules could become the first ever oral treatment for gMG
Neurofibromatosis type 1 affects an estimated 135,000 people in the EU
Around 154,270 people are expected to be diagnosed with cancer of the colon or rectum in the US this year
SpringWorks’ Gomekli was approved by the FDA earlier this year to treat patients with NF1
The neurological disorder affects more than 150,000 people in the UK
An estimated 154,270 people will be diagnosed with cancer of the colon or rectum in the US this year
The combination was approved in the US last month to treat BRAF V600E-mutant disease
The companies entered into a licensing agreement for the candidate in December last year
The deal aims to advance Merck’s viral vector manufacturing of cell and gene therapies
The alliance is aimed at accelerating the development of ADCs for cancer patients
The collaboration will utilise C4T’s TORPEDO platform to target and degrade disease-associated proteins
Ompenaclid is in phase 2 development to treat advanced or metastatic colorectal cancer
Data provided by GlobalData
GlobalData provides trusted intelligence on the world’s largest industries including Pharmaceutical and Medical Devices. With over 2,000 in-house experts, our data-driven, technology-powered approach delivers gold-standard insights to help businesses navigate complex markets and predict future trends.
Our integrated platform empowers 4,000 of the world’s largest companies—including over 70% of FTSE 100 and 60% of Fortune 100 firms—to make timely, informed decisions through unique data, expert analysis, and innovative consulting solutions.
To find out more about how our research and insights can help you, please visit https://www.globaldata.com/who-we-are/why-globaldata/
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE’s Top Pharma List – Methodology